JUL 17, 2018 11:30 PM PDT

Experimental "Trojan Horse" Tumor Destruction Approach Using CRISPR

WRITTEN BY: Mauri Brueggeman

A group of researchers are exploring a “trojan horse” tumor destruction model using the main tumor’s own cells.  They published their ideas and outcomes in the July 11, 2018 issue of Science Translational Medicine

Cancerous tumors are comprised of tumor cells that are dividing uncontrollably.  Some tumor cells will drift out into circulation and return to the main tumor site via a built in “homing” mechanism.  Researchers at Harvard have duped these roaming tumor cells into delivering cancer therapies directly to their main tumor, thereby initiating destruction of the main tumor.  Sounds like an in-body sci-fi experience written for a new fiction novel.

New gene editing technology, namely use of CRISPR-Cas9, is how this is actually possible.  Gene editing is the ability to change an organism’s physical DNA.  New sequences or genes can be added, removed, or modified within the genome.  CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9.  Bacteria use a similar genome editing mechanism naturally which is why bacteria have been primarily been used as vectors for genome editing up until very recently.  DNA is cut into small fragments and incorporated into a CRISPR locus so that when this is transcribed, the small RNAs have a new target which is then cut by the Cas9 enzyme.  In this study, the authors removed tumor cells and using CRISPR, created the expression of a death receptor on these tumor cells which causes cells to enter apoptosis.  These engineered tumor cells also included a mechanism whereby interaction with a particular drug would induce apoptosis of the engineered “trojan horse” tumor cell before it repopulated the main tumor site following loss of main tumor bulk or went on to start new tumor sites in the body. 

The study used mouse models with primary glioblastoma, recurrent glioblastoma, and breast cancer.  The therapeutic approach had discernable benefits for survival in mice; tumors were considerably reduced in size and reported that 90 percent of mice had increased survival weeks and months following the treatment intervention compared to the control mice (untreated) of which nearly 100 percent died within that same timeframe. 

There are still many unanswered questions surrounding this approach that need further investigation but the potential for using this particular unique “homing” feature of tumor cells is undeniable. 

Sources: Science Translational Medicine, NIH Genetics Home Reference, New England BioLabs, Scientific American,

 

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JAN 15, 2020
Cell & Molecular Biology
JAN 15, 2020
Cell Division Research Reveals More About a Protein That's Elevated in Cancer
Cell division is a carefully regulated process, cancer is the result when it gets out of control....
JAN 24, 2020
Immunology
JAN 24, 2020
Immune "Recycling" Could Improve Cancer Immunotherapy
A natural housekeeping function performed by many cells of the human body, including those in the immune system, is under intense scrutiny for its potentia...
JAN 23, 2020
Cancer
JAN 23, 2020
The role of circular RNA in melanoma
New research published in the journal Cancer Cell investigates the role of circular RNAs in the spread of melanoma. Melanoma is a particularly aggressive c...
JAN 20, 2020
Technology
JAN 20, 2020
Open-Source Software Judges The Accuracy of Cancer Predicting Computer Programs
Cancers are generally composed of diverse cells that vary in genetics—these variations often make a particular cancer more susceptible or resistant t...
FEB 09, 2020
Microbiology
FEB 09, 2020
Investigating the Links Between Viruses and Cancer
The Pan-Cancer Analysis of Whole Genomes (PCAWG) has brought over 1,300 scientists together to gain new insights into the genetics of cancer....
FEB 14, 2020
Cancer
FEB 14, 2020
Cataloging Cancer: DNA fingerprints at work
New research published as part of a global Pan-Cancer Project highlights the world’s most comprehensive catalog to date of DNA fingerprints of cancer...
Loading Comments...